Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | AKT2 | P31751 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2564745 | 0.78 | PDPK1 (0.47) | CHEK1AKT2 | |
| SCHEMBL16095474 | 0.77 | — | — | |
| SCHEMBL2018265 | 0.74 | KDM4E (0.38) | CYP1A2 | |
| SCHEMBL6072406 | 0.69 | KDM4E (0.36) | CYP1A2 | |
| SCHEMBL136316 | 0.68 | CYP1A2 (0.43) | CYP1A2CHEK1AKT2ADORA2AADORA2B | |
| SCHEMBL16669006 | 0.66 | ALDH1A1 (0.33) | — | |
| SCHEMBL29557196 | 0.66 | CYP1A2 (0.70) | CYP1A2CHEK1ADORA2AADORA2B | |
| SCHEMBL130625 | 0.66 | CYP1A2 (0.70) | CYP1A2CHEK1ADORA2AADORA2B | |
| SCHEMBL5652739 | 0.65 | AHR (0.47) | — | |
| SCHEMBL5497510 | 0.65 | ATM (0.47) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2969593-A1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC IMINES | Bridgestone Corporation (JP) | 2016-01-20 | — | — | EP | claimed |
| WO-2014149931-A1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC IMINES | BRIDGESTONE CORPORATION (JP) | 2014-09-25 | — | — | WO | claimed |
| EP-2969593-A1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC IMINES | Bridgestone Corporation (JP) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014149931-A1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC IMINES | BRIDGESTONE CORPORATION (JP) | 2014-09-25 | — | — | WO | disclosed |
| US-8283291-B2 | Herbicidal composition | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-20120058896-A1 | HERBICIDAL COMPOSITION | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058896-A1 | HERBICIDAL COMPOSITION | DDT, TH, CYP3A43 | CYP1A2 89/4885CHEK1 3002/4885AKT2 4380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.